American Medical Consensus on Youth Gender Medicine Is Collapsing Due to Weak Evidence
Source: Helen Lewis. "The Tide Goes Out on Youth Gender Medicine - The Atlantic." February 12, 2026. www.theatlantic.com
The Gist
Major American medical groups are backing away from supporting gender treatments for kids because the science isn't strong enough to justify the risks. They're finally admitting what critics have said all along - we don't have good evidence these treatments actually help, and some kids get better on their own without any medical intervention.
Conclusion
The medical consensus supporting youth gender medicine in America is breaking down as major medical organizations acknowledge insufficient evidence for these treatments
Premises
- The American Society of Plastic Surgeons and American Medical Association have recently recommended delaying gender-related surgeries until age 19 due to insufficient evidence
- Both organizations now endorse findings from the Cass Report and HHS review that questioned the evidence base for youth gender treatments
- Medical organizations acknowledge that gender dysphoria often resolves naturally without intervention in many children
- High-profile detransitioner lawsuits like Fox Varian's $2 million award demonstrate real harms from rushed treatments
- The suicide prevention argument for these treatments has been undermined, with advocates conceding lack of evidence for preventing completed suicides
- American practitioners largely abandoned careful assessment protocols from the original Dutch model, leading to inadequate patient evaluation
Assumptions
- Medical treatments should be based on robust evidence of benefits outweighing risks
- Professional medical organizations' position changes reflect genuine scientific concerns rather than political pressure
- The experiences of detransitioners represent a significant enough population to warrant policy changes
- Natural resolution of gender dysphoria in some children is preferable to medical intervention